Valuation Eurofins Scientific SE

Stocks

Real-time Euronext Paris Other stock markets 08:42:15 12/08/2026 BST			5-day change	1st Jan Change
69.70 ^EUR	-0.29%		+0.06%	+11.73%

07-23	Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026
07-23	Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	20,893	12,900	11,336	9,273	11,036	12,135	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	9.95%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	14,677	15,483	15,147	14,901
Change	-	-31.96%	-10.79%	-12.62%	19.63%	5.49%	-2.17%	-1.62%
P/E	27.8x	22.2x	45.4x	26.9x	28x	23.3x	18.4x	15.5x
PBR	4.49x	2.7x	2.24x	1.73x	2.56x	2.61x	2.36x	2.18x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.7x	0.7x	0.8x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.6x	1.51x	1.42x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	2.01x	2.04x	1.89x	1.74x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	8.94x	8.83x	7.97x	7.19x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	13.6x	13.5x	12x	10.6x
EV / FCF	22.8x	23.2x	29.6x	15.3x	16.7x	17.8x	15.9x	14.3x
FCF Yield	4.39%	4.3%	3.38%	6.53%	5.97%	5.63%	6.29%	7%
Dividend per Share ²	1	1	0.5	0.5	0.72	0.808	0.9164	0.9723
Rate of return	0.92%	1.49%	0.85%	1.01%	1.15%	1.16%	1.31%	1.39%
EPS ²	3.91	3.02	1.3	1.83	2.23	3.006	3.802	4.512
Distribution rate	25.6%	33.1%	38.5%	27.3%	32.3%	26.9%	24.1%	21.5%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,592	8,013	8,553
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,753	1,901	2,072
EBIT ¹	1,473	1,037	842	1,017	1,079	1,144	1,264	1,405
Net income ¹	783	606	310	406	475	532.2	661	819
Net Debt ¹	2,239	2,839	2,705	2,996	3,641	3,349	3,013	2,766
Reference price ²	108.80	67.06	58.98	49.31	62.40	69.90	69.90	69.90
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	173,599	-	-
Announcement Date	22/02/22	01/03/23	27/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EUROFINS SCIENTIFIC SE	23.25x	2.04x	8.83x	1.16%	14B
LONZA GROUP AG	33.79x	6.03x	17.93x	0.95%	49.54B
REVOLUTION MEDICINES, INC.	-21.33x	304.18x	-21.64x	-.--%	44.06B
BEONE MEDICINES AG	47.52x	5.43x	29.85x	-.--%	40.85B
IQVIA HOLDINGS INC.	31.4x	3.1x	13.37x	-.--%	40.14B
CELLTRION, INC.	32.03x	9.22x	23.17x	0.36%	34.17B
MEDPACE HOLDINGS, INC.	34.43x	5.65x	25.65x	-.--%	16.9B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	75.45x	3.98x	15.45x	-.--%	13.46B
ICON PUBLIC LIMITED COMPANY	28.05x	1.88x	11.54x	-.--%	12.78B
Average	31.62x	37.95x	13.79x	0.27%	29.54B
Weighted average by Cap.	27.50x	54.77x	12.77x	0.28%